GHK-Cu Price per Kg: Compare Active Content, MOQ and Cost-in-Use

Disclosure: We may earn a commission if you purchase through links on this page, at no additional cost to you.

Quick Answer

GHK-Cu cannot be compared fairly by the displayed price per kilogram alone. A kilogram of high-purity powder, a kilogram of 1% solution and a kilogram of 0.1% concentrate contain very different amounts of the defined Copper Tripeptide-1 material. The buyer must normalize the active basis, pack size, MOQ, assay, carrier, shipping and documentation before deciding which offer is commercially useful.

The practical rule is: first prove that the offers describe the same chemical and commercial form; then calculate cost per gram of defined active; finally calculate cost per finished batch after including wastage, testing, freight and the amount of material actually used. A lower listing price may be the more expensive option once active content and qualification work are included.

Price Comparison Starts with the Purchase Identity

The GHK-Cu identity guide separated free GHK from the copper complex (Article #51). The GHK-Cu COA guide separated HPLC area purity, defined complex content, copper content and other COA fields (Article #52). Those distinctions are also the foundation of price comparison. Do not place a free-GHK listing, a Copper Tripeptide-1 powder and a diluted blue solution in one price table simply because all three use the phrase copper peptide.

Field to normalize	Why it changes the commercial comparison
Chemical identity / CAS	Prevents related but non-equivalent peptide records from being compared
Physical form	Powder and solution have different active mass, freight, storage and handling costs
Assay basis	HPLC area purity is not automatically total mass fraction of the defined complex
Active concentration	A 1% or 0.1% solution must be converted to active mass before price ranking
Pack size and MOQ	A low unit price may require a quantity that creates cash, expiry or storage risk
Documentation	COA, TDS, identity and stability evidence reduce the cost of qualification and failure

The Core Calculation: Cost per Gram of Defined Active

For a powder, use the declared active fraction only when the supplier defines what the percentage represents and the lot COA supports the grade. A simple screening equation is:

Cost per gram of active = purchase price ÷ (purchased mass × active fraction)

Example: if a buyer receives 100 g of a material with a defined active fraction of 0.98, the nominal active-equivalent amount is 98 g before any adjustment for water, salt form, assay method or buyer-specific basis. If the price is $120, the screening cost is $120 ÷ 98 = $1.22 per nominal active-equivalent gram. This is a comparison tool, not a release assay.

For a solution, use:

Cost per gram of active = purchase price ÷ (solution mass × declared active fraction)

A 1 kg container at 1% contains 10 g of declared active before assay correction. A 1 kg container at 0.1% contains 1 g. If the two containers have the same displayed price, the 0.1% solution is ten times more expensive per declared active gram. That conclusion still requires confirmation that the stated percentage refers to the intended Copper Tripeptide-1 form and not to a carrier, peptide portion or supplier-defined premix.

Offer description	Nominal active-equivalent calculation	What remains to verify
100 g powder, 98% defined active	100 × 0.98 = 98 g	Assay basis, water/salt form, lot result
1 kg solution, 1% active	1,000 × 0.01 = 10 g	w/w basis, carrier, preservative, density if volume quoted
1 kg solution, 0.1% active	1,000 × 0.001 = 1 g	Whether 0.1% is the defined complex or another basis
500 g concentrate, 5% active	500 × 0.05 = 25 g	Final dilution instructions and stability after opening

As-Received Price Is Not Cost-in-Use

A procurement comparison should include the cost of making the material usable. For GHK-Cu, that can include identity confirmation, COA review, independent testing, pre-dissolution, batch loss, rejected material, special storage, shipping temperature control and additional formulation trials. These costs may be small for a well-documented grade and large for a cheap but ambiguous listing.

Cost component	Typical question	Commercial effect
Material price	What is the price basis: per kg, pack, gram or tier?	Avoids comparing a tier price with a single-pack quote
Active normalization	How many grams of defined active are actually purchased?	Makes powder and solution comparable
Testing	Is the supplier COA adequate for the buyer's risk?	Adds cost but can prevent a failed batch
Freight and handling	Are temperature, moisture or dangerous-goods controls relevant?	Delivered cost may exceed the listing price
Wastage / hold-up	How much is lost during weighing, transfer or filtration?	Important at small scale or with viscous concentrates
Qualification time	How many samples and document cycles are needed?	Low price with weak evidence can consume more labor

For a development project, calculate both price per nominal active gram and estimated cost per finished batch. The first supports market normalization; the second supports the actual formulation decision.

Formula-Level Cost Is the Number R&D Actually Needs

Suppose the finished formula requires a defined active amount of 0.50 g per 100 g batch. If the raw material contains 98% active, the theoretical raw-material requirement is approximately 0.50 ÷ 0.98 = 0.510 g, before process overage. If the chosen material is a 1% solution, the theoretical requirement becomes 0.50 ÷ 0.01 = 50 g of solution. The solution may still be attractive if it simplifies dissolution or improves batch reproducibility, but the comparison must include the water and carrier introduced into the formula.

Add a process factor only when it is measured or controlled. For example, if development records show a 5% handling overage is needed, apply that factor transparently. Do not invent an overage to make one supplier look better or worse. Define the target as grams of the intended active or defined complex, not only raw-material inclusion percentage. Record whether the calculation is as-received, dry-basis, anhydrous-basis or solution-strength basis. Keep the vehicle constant when comparing powder and liquid options; otherwise the test compares different formula architectures.

Include the actual commercial pack and MOQ when estimating cash tied up and expiry exposure. Recalculate after the lot COA is received if the declared assay differs from the screening assumption.

MOQ and Price Tiers Can Reverse the Ranking

A supplier may show a low price at a large quantity and a much higher price at the quantity suitable for a pilot batch. Compare offers at the buyer's real purchase scenario: sample, first pilot, first commercial lot and expected annual demand. A 25 kg price is not a useful benchmark for a buyer who needs 100 g to qualify a new formula.

MOQ also changes risk. Excess inventory can pass its retest date, require additional storage, or remain tied to a grade that is later changed. A slightly higher small-pack price may be commercially rational when it reduces qualification exposure and lets the buyer test the exact grade before committing to a large order.

How to Compare Supplier Quotes Without Inventing Market Prices

Marketplace prices are dynamic and may depend on quantity, destination, shipping, payment terms, specification and negotiation. Current offers should therefore be presented as dated sourcing observations, not as a universal market price. When the listing does not expose a usable price, record Not stated and request a formal quote rather than filling the gap with an estimate.

Use the same currency and unit basis.
Separate displayed marketplace price from quoted delivered price.
Record the price tier, pack size, MOQ and checked date.
Do not rank an offer by commission rate.
Do not call a supplier cheapest or best without a comparable evidence set.
Recheck availability, Product ID, grade and price immediately before publication or ordering.

Current GHK-Cu Sourcing Leads

Two sourcing options are listed for this article. They are RFQ entry points, not a price ranking or a quality endorsement. Request current pricing at the required pack size, exact active basis, lot COA, storage terms and shipping conditions before making a comparison.

RFQ Fields That Make Prices Comparable

Exact product identity: Copper Tripeptide-1 / GHK-Cu and the supplier grade code.
CAS and copper-containing identity statement consistent with the quoted material.
Powder or solution form, salt/counterion, carrier and preservative system.
Assay or active-content basis, method, water content and lot-specific COA availability.
Pack size, MOQ, price tiers, Incoterm, destination freight and lead time.
Storage, shelf life, retest date and packaging configuration.
Sample price, sample quantity and whether the sample is from the intended commercial grade.
Change-notification and complaint-response process.

The most useful quote is not necessarily the one with the lowest headline number. It is the one that allows the buyer to reconstruct delivered cost per defined active gram and cost per finished batch without hidden assumptions. Both links resolve to the recorded Product IDs. Affiliate Reports tracking remains a separate status. Supplier operating history and manufacturer/Verified Supplier signals should be reviewed as continuity and documentation-risk indicators; a preferred 7-8+ year history is useful, but age alone is not a quality certificate or automatic rejection rule.

Buyer Decision

Compare GHK-Cu offers by defined active content and cost-in-use, not by the largest percentage or lowest displayed kilogram price. A technically clear 1% solution can be preferable to an ambiguous powder, while a high-purity powder may be more economical when the buyer needs a concentrated active and has the process controls to handle it. The defensible sequence is:

same identity → same form basis → active-mass normalization → MOQ and delivered cost → qualification burden → finished-batch cost → RFQ decision

References

Badenhorst T, Svirskis D, Wu Z. Physicochemical characterization of native glycyl-L-histidyl-L-lysine tripeptide for wound healing and anti-aging: a preformulation study for dermal delivery. Pharmaceutical Development and Technology. 2016;21(2):152-160. doi:10.3109/10837450.2014.979944.
Yang M, Wang C, Hu D, Fu L, Wu Z. Determination of Copper Tripeptide-1 in Cosmetics by High Performance Liquid Chromatography. Journal of Organic Chemistry Research. 2022;10(4):145-150. doi:10.12677/JOCR.2022.104015.
Pingou P, et al. Quantitation of Copper Tripeptide in Cosmetics via Fabric Phase Sorptive Extraction Combined with Zwitterionic Hydrophilic Interaction Liquid Chromatography and UV-Vis Detection. Separations. 2024;11(10):293. doi:10.3390/separations11100293.
Dymek M, et al. Liposomes as Carriers of GHK-Cu Tripeptide for Cosmetic Applications. Molecules. 2023;28(21):7351. doi:10.3390/molecules28217351.

How to Compare GHK-Cu Prices: Active Content, Powder vs Solution, MOQ & Cost per Finished Batch